What role does genetics play in cancer susceptibility?

David O'Malley, Domenica Lorusso, Ana Oaknin, Toon Van Gorp, Susana Banerjee, Antonio González-Martín, Conleth Murphy, Nikolaus de Gregorio, Gottfried Konecny, Michael Method, Yuemei Wang, Robert Coleman, Ursula Matulonis, Kathleen Moore, Nicoletta Colombo

Organizations

The Ohio State University, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron, University Hospital Leuven, Leuven Cancer Institute and BGOG, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Department of Medical Oncology, Clínica Universidad de Navarra, Bon Secours Hospital Cork and Cancer Trials Ireland, Heilbronn Women's Clinic, University of California, Los Angeles Medical Center, ImmunoGen Inc., ImmunoGen, Inc, US Oncology Research, Texas Oncology and Gynecologic Oncology Group (GOG) Foundation, Dana-Farber Cancer Institute, University of Oklahoma Health Sciences Center, European Institute of Oncology

Institut Curie, University Hospital Leuven, Leuven Cancer Institute and BGOG, University of California, Los Angeles Medical Center, Hospital Universitario Virgen del Rocío and GEICO, University of Chicago Medicine, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Baystate Medical Center, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto Europeo Oncologia and MANGO, Community Health Network, Inc, Wielkopolskie Centrum Onkologii and PGOG, Maastricht University Medical Center and DGOG, Sheba Medical Center, Department of Obstetrics and Gynecology, Faculty of Medicine, University Hospital and University of Ostrava and CEEGOG, ImmunoGen, Inc, ImmunoGen Inc., Stephenson Cancer Center, Oklahoma University Health.

https://clin.larvol.com/abstract-detail/ASCO%202024/70678614